BIONIK LABORATORIES (BNKL) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 5 sessions, March 14, 2025 to December 8, 2025
- Largest daily move
- +0% close of May 5, 2025
- 1-month change
- +0% closing prices, October 21, 2025 to December 8, 2025
Company Description
BIONIK LABORATORIES (OTC: BNKL) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $1.2K.
BNKL has gained 0.0% over the past month. The last closing price was $0.0001.
For FY2023, BIONIK LABORATORIES reported revenue of $1.8M with net income of -$4.9M and diluted earnings per share of -$0.72.
This page collects what Stock Titan holds for BNKL, including price data, latest news, and financial highlights.
Stock Performance
BIONIK LABORATORIES (BNKL) closed at $0.0001 on December 8, 2025. Over the past month, the price has gained 0.0%.
BNKL Metrics & Rankings
Price returns through December 8, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BIONIK LABORATORIES has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include partnership, acquisition, earnings, conferences, management. View all BNKL news →
SEC Filings
Financial Highlights
BIONIK LABORATORIES generated $1.8M in revenue in FY2023, retaining a 54.8% gross margin, operating income reached -$4.8M, and net income was -$4.9M. Diluted earnings per share stood at -$0.72. The company generated -$3.4M in operating cash flow. The current ratio was 1.20, measuring current assets divided by current liabilities.
Upcoming Events
BNKL Company Profile & Sector Positioning
BIONIK LABORATORIES (BNKL) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BNKL often look at related companies in the same sector, including SKYLIGHT HEALTH GROUP INC (SLHGF), ATI PHYSICAL THERAPY A (ATIP), SYRA HEALTH CORP A (SYRA), CLEARDAY INC (CLRD), and GENESIS HEALTHCARE INC A (GENN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BNKL's relative position within its industry.